LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Fundamental Analysis
Europe - BIT:1CYTH - US5502411037 - Common Stock
8.179 EUR
+1.17 (+16.76%)
Overall 1CYTH gets a fundamental rating of 2 out of 10. We evaluated 1CYTH against 29 industry peers in the Diversified Telecommunication Services industry. 1CYTH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1CYTH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year 1CYTH has reported negative net income.
In the past year 1CYTH had a positive cash flow from operations.
In the past 5 years 1CYTH reported 4 times negative net income.
In the past 5 years 1CYTH always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.58%, 1CYTH is doing worse than 72.41% of the companies in the same industry.
1CYTH has a Return On Invested Capital of 1.05%. This is in the lower half of the industry: 1CYTH underperforms 75.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1CYTH is below the industry average of 7.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROIC | 1.05% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
1.3 Margins
With a Operating Margin value of 3.21%, 1CYTH is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
1CYTH's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 47.68%, 1CYTH is in line with its industry, outperforming 48.28% of the companies in the same industry.
In the last couple of years the Gross Margin of 1CYTH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% |
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CYTH is destroying value.
1CYTH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1CYTH has less shares outstanding
1CYTH has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.06, we must say that 1CYTH is in the distress zone and has some risk of bankruptcy.
1CYTH has a Altman-Z score of -0.06. This is in the lower half of the industry: 1CYTH underperforms 79.31% of its industry peers.
The Debt to FCF ratio of 1CYTH is 19.08, which is on the high side as it means it would take 1CYTH, 19.08 years of fcf income to pay off all of its debts.
1CYTH has a worse Debt to FCF ratio (19.08) than 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Altman-Z | -0.06 |
ROIC/WACC0.17
WACC6.25%
2.3 Liquidity
A Current Ratio of 2.13 indicates that 1CYTH has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.13, 1CYTH belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
A Quick Ratio of 2.10 indicates that 1CYTH has no problem at all paying its short term obligations.
1CYTH has a Quick ratio of 2.10. This is amongst the best in the industry. 1CYTH outperforms 96.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 |
3. Growth
3.1 Past
The earnings per share for 1CYTH have decreased strongly by -11.11% in the last year.
1CYTH shows a decrease in Revenue. In the last year, the revenue decreased by -6.50%.
1CYTH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.39% yearly.
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
3.2 Future
The Earnings Per Share is expected to grow by 5.71% on average over the next years.
Based on estimates for the next years, 1CYTH will show a decrease in Revenue. The Revenue will decrease by -2.87% on average per year.
EPS Next Y-223.49%
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
EPS Next 5Y5.71%
Revenue Next Year-4.81%
Revenue Next 2Y-5.15%
Revenue Next 3Y-4.24%
Revenue Next 5Y-2.87%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for 1CYTH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1CYTH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1CYTH.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1CYTH indicates a somewhat cheap valuation: 1CYTH is cheaper than 68.97% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.41 | ||
| EV/EBITDA | 7.96 |
4.3 Compensation for Growth
1CYTH's earnings are expected to decrease with -16.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
5. Dividend
5.1 Amount
1CYTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1CYTH (10/28/2025, 7:00:00 PM)
8.179
+1.17 (+16.76%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners71.63%
Inst Owner ChangeN/A
Ins Owners7.81%
Ins Owner ChangeN/A
Market Cap8.39B
Revenue(TTM)12.82B
Net Income(TTM)-1179000000
Analysts71
Price Target4.64 (-43.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-68.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.47%
Min EPS beat(2)52.11%
Max EPS beat(2)88.84%
EPS beat(4)3
Avg EPS beat(4)91.86%
Min EPS beat(4)-45.54%
Max EPS beat(4)272.03%
EPS beat(8)4
Avg EPS beat(8)-65.72%
EPS beat(12)7
Avg EPS beat(12)-22.95%
EPS beat(16)9
Avg EPS beat(16)-14.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-1.16%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)1
Avg Revenue beat(16)-1.51%
PT rev (1m)6.11%
PT rev (3m)7.88%
EPS NQ rev (1m)-1.09%
EPS NQ rev (3m)19.7%
EPS NY rev (1m)-3.19%
EPS NY rev (3m)33%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.76 | ||
| P/FCF | 10.41 | ||
| P/OCF | 2.23 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.96 |
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)0.79
FCFY9.61%
OCF(TTM)3.67
OCFY44.92%
SpS10.75
BVpS-0.5
TBVpS-4.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROCE | 1.4% | ||
| ROIC | 1.05% | ||
| ROICexc | 1.11% | ||
| ROICexgc | 1.33% | ||
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% | ||
| FCFM | 7.31% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
ROICexc(3y)3.6%
ROICexc(5y)4.47%
ROICexgc(3y)6.03%
ROICexgc(5y)8.09%
ROCE(3y)4.57%
ROCE(5y)5.8%
ROICexgc growth 3Y-47.53%
ROICexgc growth 5Y-31.85%
ROICexc growth 3Y-41.43%
ROICexc growth 5Y-24.11%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
F-Score5
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Debt/EBITDA | 5.36 | ||
| Cap/Depr | 120.27% | ||
| Cap/Sales | 26.88% | ||
| Interest Coverage | 0.31 | ||
| Cash Conversion | 133.77% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 | ||
| Altman-Z | -0.06 |
F-Score5
WACC6.25%
ROIC/WACC0.17
Cap/Depr(3y)102.09%
Cap/Depr(5y)91.52%
Cap/Sales(3y)21.07%
Cap/Sales(5y)19.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
EPS Next Y-223.49%
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
EPS Next 5Y5.71%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
Revenue Next Year-4.81%
Revenue Next 2Y-5.15%
Revenue Next 3Y-4.24%
Revenue Next 5Y-2.87%
EBIT growth 1Y-28.35%
EBIT growth 3Y-51.9%
EBIT growth 5Y-33.9%
EBIT Next Year399.42%
EBIT Next 3Y75.15%
EBIT Next 5Y39.88%
FCF growth 1Y243.21%
FCF growth 3Y-32.61%
FCF growth 5Y-18.43%
OCF growth 1Y78.32%
OCF growth 3Y-12.65%
OCF growth 5Y-8.29%
LUMEN TECHNOLOGIES INC / 1CYTH.MI FAQ
What is the ChartMill fundamental rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to 1CYTH.MI.
What is the valuation status of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to LUMEN TECHNOLOGIES INC (1CYTH.MI). This can be considered as Overvalued.
What is the profitability of 1CYTH stock?
LUMEN TECHNOLOGIES INC (1CYTH.MI) has a profitability rating of 1 / 10.
What is the financial health of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
The financial health rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) is 4 / 10.
Can you provide the expected EPS growth for 1CYTH stock?
The Earnings per Share (EPS) of LUMEN TECHNOLOGIES INC (1CYTH.MI) is expected to decline by -223.49% in the next year.